Wegener's Granulomatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of Intravenous MabThera/Rituxan in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Drug: rituximab [MabThera/Rituxan]Sponsor: Hoffmann-La RocheRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2012 Category: Research Source Type: clinical trials

A Study of Intravenous MabThera/Rituxan in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Drug: rituximab [MabThera/Rituxan]Sponsor: Hoffmann-La RocheRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2012 Category: Research Source Type: clinical trials

A Study of Intravenous MabThera/Rituxan in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Drug: rituximab [MabThera/Rituxan]Sponsor: Hoffmann-La RocheRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2012 Category: Research Source Type: clinical trials

A Study of Intravenous MabThera/Rituxan in Pediatric Patients With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Drug: rituximab [MabThera/Rituxan]Sponsor: Hoffmann-La RocheRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2012 Category: Research Source Type: clinical trials

PRO Development for ANCA Associated Vasculitis
Conditions: Wegener Granulomatosis; Microscopic Polyangiitis; Churg-Strauss SyndromeIntervention: Sponsor: University of OxfordActive, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2012 Category: Research Source Type: clinical trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Wegener's Granulomatosis, Microscopic PolyangiitisIntervention: Sponsor: Genentech, Inc.Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2012 Category: Research Source Type: clinical trials